[HTML][HTML] Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants

J Yin, C Li, C Ye, Z Ruan, Y Liang, Y Li, J Wu… - Computational and …, 2022 - Elsevier
Abstract Since Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was
identified in late 2019, the coronavirus disease 2019 (COVID-19) pandemic has challenged …

[HTML][HTML] Therapeutic strategies against COVID-19 and structural characterization of SARS-CoV-2: a review

GU Jeong, H Song, GY Yoon, D Kim… - Frontiers in …, 2020 - frontiersin.org
The novel coronavirus, SARS-CoV-2, or 2019-nCoV, which originated in Wuhan, Hubei
province, China in December 2019, is a grave threat to public health worldwide. A total of …

Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus

CA Omolo, N Soni, VO Fasiku, I Mackraj… - European Journal of …, 2020 - Elsevier
The global pandemic of coronavirus disease 2019 (COVID-19), caused by novel severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in over 7,273,958 …

Emerging strategies on in silico drug development against COVID-19: challenges and opportunities

M Yadav, S Dhagat, JS Eswari - European Journal of Pharmaceutical …, 2020 - Elsevier
The importance of coronaviruses as human pathogen has been highlighted by the recent
outbreak of SARS-CoV-2 leading to the search of suitable drugs to overcome respiratory …

Structure-based drug designing and immunoinformatics approach for SARS-CoV-2

PK Panda, MN Arul, P Patel, SK Verma, W Luo… - Science …, 2020 - science.org
The prevalence of respiratory illness caused by the novel SARS-CoV-2 virus associated with
multiple organ failures is spreading rapidly because of its contagious human-to-human …

A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19

K Sharun, R Tiwari, MI Yatoo, S Natesan, D Megawati… - Narra J, 2022 - narraj.org
The emergence of coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has affected many countries throughout …

[HTML][HTML] Genomics insights of SARS-CoV-2 (COVID-19) into target-based drug discovery

P Chellapandi, S Saranya - Medicinal Chemistry Research, 2020 - Springer
Abstract Coronavirus disease (COVID-19) pandemic is caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is a global health emergency and no …

Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection

P Khare, U Sahu, SC Pandey, M Samant - Virus research, 2020 - Elsevier
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) recently caused a
pandemic outbreak called coronavirus disease 2019 (COVID-19). This disease has initially …

[HTML][HTML] Identification of multipotent drugs for COVID-19 therapeutics with the evaluation of their SARS-CoV2 inhibitory activity

S Kumar, B Singh, P Kumari, PV Kumar… - Computational and …, 2021 - Elsevier
The SARS-CoV2 is a highly contagious pathogen that causes COVID-19 disease. It has
affected millions of people globally with an average lethality of~ 3%. There is an urgent need …

In-silico strategies to combat COVID-19: A comprehensive review

S Basu, S Ramaiah, A Anbarasu - Biotechnology and Genetic …, 2021 - Taylor & Francis
The novel coronavirus SARS-CoV-2 since its emergence at Wuhan, China in December
2019 has been creating global health turmoil despite extensive containment measures and …